Stressed SIRT7: facing a crossroad of senescence and immortality

被引：7
|
作者：
Liu, Jun-Ping [1 ,2 ,3 ]
Chen, Ruping [1 ]
机构：
[1] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China
[2] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia
[3] Hudson Inst Med Res, Melbourne, Vic, Australia
来源：
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2015年 / 42卷 / 06期
关键词：
ageing; cancer; hematopoietic stem cells; immortality; longevity; senescence;
D O I：
10.1111/1440-1681.12423
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SIRT7 with coenzyme NAD catalyzes protein de-acetylation. In stress response, SIRT7 regulates protein folding in mitochondria with unknown mechanisms. Decreases in SIRT7 entrain hematopoietic stem cell senescence, but increasing SIRT7 causes elevation of hematopoietic stem cell regenerative function. We discuss the recent findings on SIRT7 and its binding proteins, NRF1 and GABP1, in decision making between the choices of inducing cell aging and immortality.
引用
收藏
页码：567 / 569
页数：3
相关论文
共 50 条
  • [31] Comparative interactomes of SIRT6 and SIRT7: Implication of functional links to aging
    Lee, Namgyu
    Kim, Dae-Kyum
    Kim, Eung-Sam
    Park, Sung Jin
    Kwon, Jung-Hee
    Shin, Jihye
    Park, Seon-Min
    Moon, Young Ho
    Wang, Hee Jung
    Gho, Yong Song
    Choi, Kwan Yong
    PROTEOMICS, 2014, 14 (13-14) : 1610 - 1622
  • [32] Structural basis of SIRT7 nucleosome engagement and substrate specificity
    Moreno-Yruela, Carlos
    Ekundayo, Babatunde E.
    Foteva, Polina N.
    Ni, Dongchun
    Calvino-Sanles, Esther
    Stahlberg, Henning
    Fierz, Beat
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [33] Identification of a novel SIRT7 inhibitor as anticancer drug candidate
    Kim, Ji-Hye
    Kim, Dahee
    Cho, Suk Joon
    Jung, Kwan-Young
    Kim, Jong-Hoon
    Lee, Jun Mi
    Jung, Hee Jung
    Kim, Kwang Rol
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 508 (02) : 451 - 457
  • [34] SIRT7: a novel molecular target for personalized cancer treatment?
    Alessandro Ianni
    Poonam Kumari
    Shahriar Tarighi
    Thomas Braun
    Alejandro Vaquero
    Oncogene, 2024, 43 : 993 - 1006
  • [35] SIRT7: a novel molecular target for personalized cancer treatment?
    Ianni, Alessandro
    Kumari, Poonam
    Tarighi, Shahriar
    Braun, Thomas
    Vaquero, Alejandro
    ONCOGENE, 2024, 43 (14) : 993 - 1006
  • [36] Sirt7 protects against vascular calcification via modulation of reactive oxygen species and senescence of vascular smooth muscle cells
    Yu, Hongjiao
    Xie, Yuchen
    Lan, Lan
    Ma, Siyu
    Mok, Simon Wing Fai
    Wong, Io Nam
    Wang, Yueheng
    Zhong, Guoli
    Yuan, Liang
    Zhao, Huan
    Hu, Xiao
    Macrae, Vicky E.
    He, Shengping
    Chen, Guojun
    Zhu, Dongxing
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 223 : 30 - 41
  • [37] SIRT7 epigenetically regulates MITF to promote melanoma growth
    Guo, W.
    Ma, J.
    Pei, T.
    Wang, S.
    Guo, S.
    Gao, T.
    Li, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S204 - S204
  • [38] The controversial role of Sirtuins in tumorigenesis - SIRT7 joins the debate
    Li, Ling
    Bhatia, Ravi
    CELL RESEARCH, 2013, 23 (01) : 10 - 12
  • [39] Sirt7 Regulates Wound Healing by Modulating TGFβ Signaling
    Araki, Satoshi
    Izumiya, Yasuhiro
    Rokutanda, Taku
    Hanatani, Shinsuke
    Kimura, Yuichi
    Bober, Eva
    Braun, Thomas
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [40] SIRT7 Is an RNA-Activated Protein Lysine Deacylase
    Tong, Zhen
    Wang, Miao
    Wang, Yi
    Kim, David D.
    Grenier, Jennifer K.
    Cao, Ji
    Sadhukhan, Sushabhan
    Hao, Quan
    Lin, Hening
    ACS CHEMICAL BIOLOGY, 2017, 12 (01) : 300 - 310
12345